A citation-based method for searching scientific literature


List of co-cited articles
324 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


A note on confidence intervals in cost-effectiveness analysis.
M Tambour, N Zethraeus, M Johannesson. Int J Technol Assess Health Care 1998
106
14


Recommendations for Conduct, Methodological Practices, and Reporting of Cost-effectiveness Analyses: Second Panel on Cost-Effectiveness in Health and Medicine.
Gillian D Sanders, Peter J Neumann, Anirban Basu, Dan W Brock, David Feeny, Murray Krahn, Karen M Kuntz, David O Meltzer, Douglas K Owens, Lisa A Prosser,[...]. JAMA 2016
12



Costs, effects and C/E-ratios alongside a clinical trial.
B A van Hout, M J Al, G S Gordon, F F Rutten. Health Econ 1994
692
10

Cost-effectiveness acceptability curves--facts, fallacies and frequently asked questions.
Elisabeth Fenwick, Bernie J O'Brien, Andrew Briggs. Health Econ 2004
607
9

Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L).
M Herdman, C Gudex, A Lloyd, Mf Janssen, P Kind, D Parkin, G Bonsel, X Badia. Qual Life Res 2011
8

Methods for the estimation of the National Institute for Health and Care Excellence cost-effectiveness threshold.
Karl Claxton, Steve Martin, Marta Soares, Nigel Rice, Eldon Spackman, Sebastian Hinde, Nancy Devlin, Peter C Smith, Mark Sculpher. Health Technol Assess 2015
390
7






Calculating and Interpreting ICERs and Net Benefit.
Mike Paulden. Pharmacoeconomics 2020
28
21

EuroQol: the current state of play.
R Brooks. Health Policy 1996
5



A guide to cost-effectiveness acceptability curves.
Elisabeth Fenwick, Sarah Byford. Br J Psychiatry 2005
269
5


Consolidated Health Economic Evaluation Reporting Standards (CHEERS)--explanation and elaboration: a report of the ISPOR Health Economic Evaluation Publication Guidelines Good Reporting Practices Task Force.
Don Husereau, Michael Drummond, Stavros Petrou, Chris Carswell, David Moher, Dan Greenberg, Federico Augustovski, Andrew H Briggs, Josephine Mauskopf, Elizabeth Loder. Value Health 2013
5


Country-Level Cost-Effectiveness Thresholds: Initial Estimates and the Need for Further Research.
Beth Woods, Paul Revill, Mark Sculpher, Karl Claxton. Value Health 2016
401
5

Updating cost-effectiveness--the curious resilience of the $50,000-per-QALY threshold.
Peter J Neumann, Joshua T Cohen, Milton C Weinstein. N Engl J Med 2014
5


Interim scoring for the EQ-5D-5L: mapping the EQ-5D-5L to EQ-5D-3L value sets.
Ben van Hout, M F Janssen, You-Shan Feng, Thomas Kohlmann, Jan Busschbach, Dominik Golicki, Andrew Lloyd, Luciana Scalone, Paul Kind, A Simon Pickard. Value Health 2012
934
4

Multiple imputation using chained equations: Issues and guidance for practice.
Ian R White, Patrick Royston, Angela M Wood. Stat Med 2011
4


Calculating partial expected value of perfect information via Monte Carlo sampling algorithms.
Alan Brennan, Samer Kharroubi, Anthony O'hagan, Jim Chilcott. Med Decis Making 2007
78
5

A Gaussian Approximation Approach for Value of Information Analysis.
Hawre Jalal, Fernando Alarid-Escudero. Med Decis Making 2018
28
14


The decision rules of cost-effectiveness analysis.
G Karlsson, M Johannesson. Pharmacoeconomics 1996
130
4


Advantages of using the net-benefit approach for analysing uncertainty in economic evaluation studies.
Niklas Zethraeus, Magnus Johannesson, Bengt Jönsson, Mickael Löthgren, Magnus Tambour. Pharmacoeconomics 2003
85
4

Why it's Time to Abandon the ICER.
Mike Paulden. Pharmacoeconomics 2020
11
36

Probabilistic sensitivity analysis for NICE technology assessment: not an optional extra.
Karl Claxton, Mark Sculpher, Chris McCabe, Andrew Briggs, Ron Akehurst, Martin Buxton, John Brazier, Tony O'Hagan. Health Econ 2005
287
4


Enhanced secondary analysis of survival data: reconstructing the data from published Kaplan-Meier survival curves.
Patricia Guyot, A E Ades, Mario J N M Ouwens, Nicky J Welton. BMC Med Res Methodol 2012
932
4

Lenvatinib versus sorafenib in first-line treatment of patients with unresectable hepatocellular carcinoma: a randomised phase 3 non-inferiority trial.
Masatoshi Kudo, Richard S Finn, Shukui Qin, Kwang-Hyub Han, Kenji Ikeda, Fabio Piscaglia, Ari Baron, Joong-Won Park, Guohong Han, Jacek Jassem,[...]. Lancet 2018
4

Is there a kink in consumers' threshold value for cost-effectiveness in health care?
Bernie J O'Brien, Kirsten Gertsen, Andrew R Willan, Lisa A Faulkner. Health Econ 2002
102
4

Value of Information Analytical Methods: Report 2 of the ISPOR Value of Information Analysis Emerging Good Practices Task Force.
Claire Rothery, Mark Strong, Hendrik Erik Koffijberg, Anirban Basu, Salah Ghabri, Saskia Knies, James F Murray, Gillian D Sanders Schmidler, Lotte Steuten, Elisabeth Fenwick. Value Health 2020
32
12


Systematic Review and Meta-Analysis of Cost-effectiveness of Rotavirus Vaccine in Low-Income and Lower-Middle-Income Countries.
Sabbir Haider, Usa Chaikledkaew, Montarat Thavorncharoensap, Sitaporn Youngkong, Md Ashadul Islam, Ammarin Thakkinstian. Open Forum Infect Dis 2019
25
16

Cost Utility of Sodium-Glucose Cotransporter 2 Inhibitors in the Treatment of Metformin Monotherapy Failed Type 2 Diabetes Patients: A Systematic Review and Meta-Analysis.
Bhavani Shankara Bagepally, Yogesh Krishnarao Gurav, Thunyarat Anothaisintawee, Sitaporn Youngkong, Usa Chaikledkaew, Ammarin Thakkinstian. Value Health 2019
16
25

Comparative efficiency research (COMER): meta-analysis of cost-effectiveness studies.
Carlos Crespo, Antonio Monleon, Walter Díaz, Martín Ríos. BMC Med Res Methodol 2014
19
21



Estimating the Reference Incremental Cost-Effectiveness Ratio for the Australian Health System.
Laura Catherine Edney, Hossein Haji Ali Afzali, Terence Chai Cheng, Jonathan Karnon. Pharmacoeconomics 2018
99
3

Using Cost-Effectiveness Analysis to Address Health Equity Concerns.
Richard Cookson, Andrew J Mirelman, Susan Griffin, Miqdad Asaria, Bryony Dawkins, Ole Frithjof Norheim, Stéphane Verguet, Anthony J Culyer. Value Health 2017
115
3

Research electronic data capture (REDCap)--a metadata-driven methodology and workflow process for providing translational research informatics support.
Paul A Harris, Robert Taylor, Robert Thielke, Jonathon Payne, Nathaniel Gonzalez, Jose G Conde. J Biomed Inform 2009
3


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.